摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,5-dimethyl-2H-3,1-benzoxazine-2,4(1H)-dione | 55150-23-7

中文名称
——
中文别名
——
英文名称
1,5-dimethyl-2H-3,1-benzoxazine-2,4(1H)-dione
英文别名
N-methyl-6-methylisatoic anhydride;1,5-dimethyl-2H-benzo[d][1,3]oxazine-2,4(1H)-dione;1,5-dimethyl-1H-benzo[d][1,3]oxazine-2,4-dione;5-methyl-1-methyl-3,1-benzoxazine-2,4(1H)-dione;1,5-dimethyl-3,1-benzoxazine-2,4-dione
CAS
55150-23-7
化学式
C10H9NO3
mdl
——
分子量
191.186
InChiKey
JWHROJKTXVVPHP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    14
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    46.6
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1,5-dimethyl-2H-3,1-benzoxazine-2,4(1H)-dione盐酸 、 sodium hydride 作用下, 以 溶剂黄146N,N-二甲基甲酰胺 为溶剂, 反应 11.0h, 生成 4-Hydroxy-1,5-dimethyl-2-oxo-1,2-dihydro-quinoline-3-carboxylic acid
    参考文献:
    名称:
    Synthesis and Biological Evaluation of New 1,2-Dihydro-4-hydroxy-2-oxo-3-quinolinecarboxamides for Treatment of Autoimmune Disorders:  Structure−Activity Relationship
    摘要:
    Roquinimex-related 3-quinolinecarboxamide derivatives were prepared and evaluated for treatment of autoimmune disorders. The compounds were tested in mice for their inhibitory effects on disease development in the acute experimental autoimmune encephalomyelitis model and selected compounds in the beagle dog for induction of proinflammatory reaction. Structure-activity relationships are discussed. Compound 8c, laquinimod, showed improved potency and superior toxicological profile compared to the lead compound roquinimex (1b, Linomide) and was selected for clinical studies (currently in phase II).
    DOI:
    10.1021/jm031044w
  • 作为产物:
    描述:
    2-氨基-6-甲基苯甲酸 在 sodium hydride 作用下, 以 四氢呋喃N,N-二甲基甲酰胺 为溶剂, 反应 6.5h, 生成 1,5-dimethyl-2H-3,1-benzoxazine-2,4(1H)-dione
    参考文献:
    名称:
    吴茱萸碱衍生物作为有效杀虫剂候选物的发现
    摘要:
    在寻找新型更有效的杀虫剂时,天然产物具有良好的环境相容性、多种生物活性、独特的支架和作用方式,可作为理想的模板化合物。我们发现吴茱萸果实的主要活性成分天然产物吴茱萸碱对鳞翅目具有明显的杀虫活性。害虫。为了继续我们的研究,我们合理设计和合成了一系列吴茱萸碱衍生物3a-3aa。杀幼虫活性结果表明,大部分目标化合物对Mythimna separata、Plutella xylostella和Helicoverpa armigera的效果优于吴茱萸碱、苦参碱和鱼藤酮,其中3z表现出优异的杀幼虫活性(2.5 mg/L对M. separata的杀幼虫活性为65%, 75% 1.0 mg/L 对P. xylostella和 85% 10 mg/L 对H. armigera,分别),远优于吴茱萸碱(0%)、苦参碱(0%)和鱼藤酮(0%)。初步构效关系表明吴茱萸碱E环上的氟原子对杀幼虫活性有正向影响。钙显像
    DOI:
    10.1016/j.bmc.2022.116727
点击查看最新优质反应信息

文献信息

  • QUINAZOLINE-2,4-DIONE DERIVATIVES
    申请人:Hubschwerlen Christian
    公开号:US20140171425A1
    公开(公告)日:2014-06-19
    The invention relates to antibacterial compounds of formula (I), wherein R 1 is H, halogen, (C 1 -C 3 )alkyl or (C 1 -C 3 )alkoxy; R 2 is H, halogen, (C 1 -C 3 )alkyl, (C 1 -C 3 )alkoxy or pyrrolidin-1-yl; R 3 is H, halogen, (C 1 -C 3 )alkyl, (C 1 -C 3 )alkoxy, vinyl or 2-methoxycarbonyvinyl or R 2 and R 3 together with the two carbon atoms which bear them form a phenyl ring; R 4 is H, halogen, (C 1 -C 3 )alkyl or (C 1 -C 3 )alkoxy; and R 5 is H, (C 1 -C 3 )alkyl or cyclopropyl, or R 4 and R 5 form together a —CH 2 CH 2 CH 2 — group; A is the divalent group —CH 2 —, —CH 2 CH 2 —, #—CH(OH)CH 2 —*, #—CH 2 N(R 6 )—* and —CH 2 NHCH 2 —, wherein # indicates the point of attachment to the optionally substituted (quinazoline-2,4-dione-3-yl)methyl residue and * represents the point of attachment to the substituted (oxazolidinon-4-yl)methyl residue; R 6 is H or acetyl; Y is CH or N; and Q is O or S; and salts of such compounds.
    该发明涉及式(I)的抗菌化合物,其中R1为H、卤素、(C1-C3)烷基或(C1-C3)氧烷;R2为H、卤素、(C1-C3)烷基、(C1-C3)氧烷或吡咯烷-1-基;R3为H、卤素、(C1-C3)烷基、(C1-C3)氧烷、乙烯基或2-甲氧羰基乙烯基,或R2和R3与携带它们的两个碳原子一起形成苯环;R4为H、卤素、(C1-C3)烷基或(C1-C3)氧烷;R5为H、(C1-C3)烷基或环丙基,或R4和R5一起形成一个— —基团;A为二价基团—CH2—、— —、#—CH(OH) —*、#— N(R6)—*和— NH —,其中#表示可选择取代的(喹唑啉-2,4-二酮-3-基)甲基残基的连接点,*表示取代的(噁唑烷酮-4-基)甲基残基的连接点;R6为H或乙酰基;Y为CH或N;Q为O或S;以及这类化合物的盐。
  • [EN] QUINAZOLINE-2,4-DIONE DERIVATIVES<br/>[FR] DÉRIVÉS DE QUINAZOLINE-2,4-DIONE
    申请人:ACTELION PHARMACEUTICALS LTD
    公开号:WO2013021363A1
    公开(公告)日:2013-02-14
    The invention relates to antibacterial compounds of formula (I), wherein R1 is H, halogen, (C1-C3)alkyl or (C1-C3)alkoxy; R2 is H, halogen, (C1-C3)alkyl, (C1-C3)alkoxy or pyrrolidin-l-yl; R3 is H, halogen, (C1-C3)alkyl, (C1-C3)alkoxy, vinyl or 2-methoxycarbonylvinyl or R2 and R3 together with the two carbon atoms which bear them form a phenyl ring; R4 is H, halogen, (C1-C3)alkyl or (C1-C3)alkoxy and R5 is H, (C1-C3)alkyl or cyclopropyl, or R4 and R5 form together a -CH2CH2CH2- group; A is the divalent group -CH2-, -CH2CH2-, #-CH(OH)CH2-*, #-CH2N(R6)-* or -CH2NHCH2-, wherein # indicates the point of attachment to the optionally substituted (quinazoline-2,4-dione-3-yl)methyl residue and * represents the point of attachment to the substituted (oxazolidinon-4-yl)methyl residue; R6 is H or acetyl; Y is CH or N; and Q is O or S; and salts of such compounds.
    该发明涉及式(I)的抗菌化合物,其中R1为H、卤素、(C1-C3)烷基或(C1-C3)氧烷基;R2为H、卤素、(C1-C3)烷基、(C1-C3)氧烷基或吡咯烷-1-基;R3为H、卤素、(C1-C3)烷基、(C1-C3)氧烷基、乙烯基或2-甲氧羰基乙烯基,或者R2和R3与它们所连接的两个碳原子一起形成苯环;R4为H、卤素、(C1-C3)烷基或(C1-C3)氧烷基,R5为H、(C1-C3)烷基或环丙基,或者R4和R5一起形成一个- -基团;A为二价基团-CH2-、- -、#-CH(OH) -*、#- N(R6)-*或- NH -,其中#表示可选择取代的(喹唑啉-2,4-二酮-3-基)甲基残基的连接点,*表示取代的(噁唑烷酮-4-基)甲基残基的连接点;R6为H或乙酰基;Y为CH或N;Q为O或S;以及这类化合物的盐。
  • Synthesis of Ring-Fused, N-Substituted 4-Quinolinones Using p<i>K</i><sub>a</sub>-Guided, Base-Promoted Annulations with Isatoic Anhydrides: Total Synthesis of Penicinotam
    作者:Muhammad M. Khalifa、Satish Chandra Philkhana、Jennifer E. Golden
    DOI:10.1021/acs.joc.9b02541
    日期:2020.1.17
    deprotonation susceptibility, such as tetramic and tetronic acids, cyclic 1,3-diketones, and cycloalkanones. Application to the synthesis of bioactive, pyrrolizine-fused 4-quinolinone, penicinotam 3, resulted in the most brief and highest yielding total synthesis of the alkaloid in three steps and a 36% overall yield.
    开发了一种使用等位酸酐和多种可烯化伙伴的阴离子环化策略,以提供80多种新型的环稠合N取代的4-喹啉酮,这是一种代表性不足的特权模板。确定了控制转化效率的多种因素,从而形成了可靠且可调谐的合成平台,适用于具有多种去质子化敏感性的多种底物,例如四甲酸和四氢代酸,环状1,3-二酮和环烷酮。应用于生物活性的吡咯烷嗪融合的4-喹啉青霉素3的合成中,生物碱的合成过程最简单,最高,分三步进行,总产率为36%。
  • 1,3-Dipolar Cycloaddition−Decarboxylation Reactions of an Azomethine Ylide with Isatoic Anhydrides: Formation of Novel Benzodiazepinones
    作者:Nadia Spiccia、Jose Basutto、Pawel Jokisz、Leon S.-M. Wong、Adam G. Meyer、Andrew B. Holmes、Jonathan M. White、John H. Ryan
    DOI:10.1021/ol102824k
    日期:2011.2.4
    substituted isatoic anhydrides to afford novel 1,3-benzodiazepin-5-one derivatives, which are generally isolated in high yield. The transformations involve 1,3-dipolar cycloaddition reactions of the ylide with the anhydrides to give transient, and in a representative case spectroscopically observable, oxazolidine intermediates that undergo ring-opening−decarboxylation−ring-closing reaction cascades to
    不稳定的偶氮甲亚胺叶立德与各种取代的等角酸酐反应,得到新的1,3-苯并二氮杂-1-基五酮衍生物,通常以高收率分离。转化涉及叶立德与酸酐的1,3-偶极环加成反应,以产生瞬态,在光谱学上可观察到的典型情况下,恶唑烷中间体经历开环-脱羧-闭环反应级联反应生成1,3-苯并二氮杂-5-酮产品。
  • Medium-Sized-Ring Analogues of Dibenzodiazepines by a Conformationally Induced Smiles Ring Expansion
    作者:Romain Costil、Quentin Lefebvre、Jonathan Clayden
    DOI:10.1002/anie.201708991
    日期:2017.11.13
    heterocycles requires no electronic activation to give medium-sized-ring analogues of the dibenzodiazepine tricyclic antidepressants.⋅The reaction tolerates electron-rich and electron-poor rings, delivers 9-12-membered rings, and leads to conformationally restricted products
    斯迈尔斯苯并稠合含氮杂环的容易地制备酰胺衍生物的重排不要求电子活化,得到dibenzodiazepine三环antidepressants.⋅The反应容忍富电子和贫电子的环,可提供的中型环类似物9-12元环,并导致构象受限的产品
查看更多